Form 8-K - Current report:
SEC Accession No. 0001193125-24-252153
Filing Date
2024-11-06
Accepted
2024-11-06 16:43:03
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826537d8k.htm   iXBRL 8-K 27368
2 EX-99.1 d826537dex991.htm EX-99.1 95944
7 GRAPHIC g826537g1105105850017.jpg GRAPHIC 4016
  Complete submission text file 0001193125-24-252153.txt   298453

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20241106.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20241106_def.xml EX-101.DEF 13652
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20241106_lab.xml EX-101.LAB 22564
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20241106_pre.xml EX-101.PRE 14620
18 EXTRACTED XBRL INSTANCE DOCUMENT d826537d8k_htm.xml XML 5700
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 241431743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)